Butyrate enhances the production of nitric oxide in mouse vascular endothelial cells in response to gamma interferon

Journal of Endotoxin Research

Volumn 10, Issue 1, 2004, Pages 33-38

  Morikawa, Akiko ^a   Sugiyama, Tsuyoshi ^a   Koide, Naoki ^a   Mori, Isamu ^a   Mu, Mya Mya ^a   Yoshida, Tomoaki ^a   Hassan, Ferdaus ^a   Islam, Shamima ^a   Yokochi, Takashi ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Butyrate; IFN ; Mouse vascular endothelial cells; Nitric oxide

Indexed keywords

BUTYRIC ACID; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; JANUS KINASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; ANTINEOPLASTIC AGENT; BUTYRIC ACID DERIVATIVE; PROTEIN TYROSINE KINASE; SCAVENGER;

ANIMAL CELL; ARTICLE; BACTERIAL FLORA; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CELL STIMULATION; COLON FLORA; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; TIME; VASCULAR ENDOTHELIUM; ANIMAL; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); JANUS; MURINAE;

ANIMALS; ANTINEOPLASTIC AGENTS; BUTYRATES; CELL LINE; DOWN-REGULATION; ENDOTHELIAL CELLS; FREE RADICAL SCAVENGERS; INTERFERON TYPE II; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 85047171531     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/09680519040100010401     Document Type: Article

References (21)

1. Cummings JH, Pomare EW, Branch WJ et al. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987; 28: 1221-1227.
2. Treem WR, Ahsan N, Shoup M, Hyams J. Fecal short chain fatty acids in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1994; 18: 159-164.
3. Dabard J, Hudault S, Saby MA et al. Production of butyric acid in human premature baby suffering from necrotizing enterocolitis. Proceedings of the 9th International Symposium on Gnotobiology, Versailles, 1987; 90-95.
4. Fukushima K, Sasaki I, Takahashi K et al. Lipopolysaccharide exhibits synergistic enhancement of butyrate-induced and retinoic acid mediated alkaline phosphatase activity on small intestinal epithelial cell line, IEC-6. Digestion 1998; 59: 683-688.
5. Segain JP, Raingeard de la Bletiere D, Bourreille A et al. Butyrate inhibits inflammatory responses through NF-kappaB inhibition: implications for Crohn's disease. Gut 2000; 47: 397-403.
6. Chakravortty D, Koide N, Kato Y et al. The inhibitory action of butyrate on lipopolysaccharide-induced nitric oxide production in RAW 264.7 murine macrophage cells. J Endotoxin Res 2000; 6: 243-247.
7. 2 production and modulates immune function. J Surg Res 1998; 78: 1-6.
8. Fusunyan RD, Quinn JJ, Ohno Y et al. Butyrate enhances interleukin (IL)-8 secretion by intestinal epithelial cells in response to IL-1β and lipopolysaccharide. Pediatr Res 1998; 43: 84-90.
9. Tsuneoka K, Shikita M. A colony-stimulating factor for neutrophil granulocytes: A marked increase of its production by the addition of sodium butyrate and lipopolysaccharide in serum-free culture of RSP-2 × P3 cells. J Cell Physiol 1985; 125: 436-442.
10. Wang LS, Chow KC, Wu CW. Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate. Br J Cancer 1999; 80: 1617-1622.
11. Morikawa A, Koide N, Kato Y et al. Augmentation of nitric oxide production by gamma interferon in a mouse vascular endothelial cell line and its modulation by tumor necrosis factor alpha and lipopolysaccharide. Infect Immun 2000; 68: 6209-6214.
12. Green LC, Wagner DDA, Glowgowski J et al. Analysis of nitrate, nitrite and 15N nitrate in biological fluids. Anal Biochem 1982; 1236: 131-138.
13. Csordas A. Butyrate, aspirin and colorectal cancer. Eur J Cancer Prev 1996; 5: 221-231.
14. Loidl P, Loidl A, Puschendorf B, Grobner P. Lack of correlation between histone H4 acetylation and transcription during the Physarum cell cycle. Nature 1983; 305: 446-448.
15. Yamamoto I, Matsunaga T, Sakata K, Nakamura Y, Doi S, Hanmyou F. Histone hyperacetylation plays a role in augmentation of IL-4-induced IgE production in LPS-stimulated murine B-lymphocytes by sodium butyrate. J Biochem (Tokyo) 1996; 119: 1056-1061.
16. Okamura T, Gohda E, Kohge T, Yamamoto I. An increase in histone acetylation and IL-2 antagonizing the immunoinhibitory effect are necessary for augmentation by butyrate of in vitro anti-TNP antibody production. Biol Pharm Bull 1999; 22: 1288-1292.
17. Tsuneoka K, Shikita M. A colony-stimulating factor for neutrophil granulocytes: A marked increase of its production by the addition of sodium butyrate and lipopolysaccharide in serum-free culture of RSP-2 × P3 cells. J Cell Physiol 1985; 125: 436-442.
18. Yamamoto I, Adachi T, Kishiro Y, Fujiwara M, Gohda E. Interleukin-2-dependent augmentation of the anti-TNP antibody production by sodium butyrate in cultured murine splenic B cells. Int J Immunopharmacol 1997; 19: 347-354.
19. Ohno Y, Lee J, Fusunyan RD, MacDermott RP, Sanderson IR. Macrophage inflammatory protein-2: Chromosomal regulation in rat small intestinal epithelial cells. Proc Natl Acad Sci USA 1997; 94: 10279-10284.
20. Sealy L, Chalkley R. The effect of sodium butyrate on histone modification. Cell 1978; 14: 115-121.
21. Candido EP, Reeves R, Davie JR. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 1978; 14: 105-113.